(MENAFN - Baystreet) 10:38 AM EST - Medicenna Therapeutics Corp.: Today reported financial results for the three months ended June 30, 2026. The Company reported total operating costs of $5.4 ...
This is a summary. For the full story, refer to the original source. Public of India presents verified citizen-relevant reporting.